Source comparison
Melanotan-1 Administration: Protocol Comparison
Typical Dose Range 0.16–1.0 mg/kg body weight 0.1–0.5 mg fixed dose 0.05–0.2 mg microdosing Photoprotection requires weight-based dosing due to systemic melanin distribution; receptor studies use fixed microdoses to isolate binding without triggering downstrea
This comparison does not assign a generated winner or score.
- Typical Dose Range
- 0.16–1.0 mg/kg body weight
- 0.1–0.5 mg fixed dose
- 0.05–0.2 mg microdosing
- Photoprotection requires weight-based dosing due to systemic melanin distribution; receptor studies use fixed microdoses to isolate binding without triggering downstream melanogenesis
- Administration Frequency
- Once every 48–72 hours
- Daily during induction, then maintenance
- Single dose per experiment
- Frequent dosing in photoprotection maintains elevated alpha-MSH receptor occupancy; receptor studies avoid repeat dosing to prevent tachyphylaxis
- Injection Site
- Abdomen only (standardised)
- Rotation protocol (abdomen/thigh)
- Abdomen only
- Site standardisation eliminates absorption variability in photoprotection trials where systemic effect is measured; rotation protocols prevent lipohypertrophy in longer studies
- Reconstitution Solvent
- Bacteriostatic water
- Sterile saline (single-use)
- Bacteriostatic water extends multi-dose vial stability; single-dose receptor studies use sterile saline to avoid benzyl alcohol interference with assay chemistry
- Monitoring Parameters
- Skin melanin density, minimal erythemal dose (MED)
- Plasma alpha-MSH, tyrosinase activity
- Receptor occupancy via radiolabelling
- Photoprotection measures clinical endpoints (MED increase); melanogenesis tracks biochemical intermediates; receptor studies isolate binding without functional activation